{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:52:10Z","timestamp":1769856730231,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.lungcan.2007.06.001","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T07:10:45Z","timestamp":1185261045000},"page":"422-424","source":"Crossref","is-referenced-by-count":17,"title":["Gefitinib administration in a patient with lung cancer undergoing hemodialysis"],"prefix":"10.1016","volume":"58","author":[{"given":"Naofumi","family":"Shinagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Asahina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Agata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2007.06.001_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2007.06.001_bib2","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2003.10.038","article-title":"Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer","volume":"21","author":"Fukuoka","year":"2003","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.lungcan.2007.06.001_bib3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/sj.bjc.6601479","article-title":"Lessons from the \u201cIrresa\u201d Expanded Access Program: gefitinib in special non-small-cell lung cancer patient populations","volume":"89","author":"Stahel","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2007.06.001_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0731-7085(02)00014-6","article-title":"A sensitive assay for ZD1839 (Irressa) in human plasma by liquid\u2013liquid extraction and high performance liquid chromatography with mass spectrometric detection: validation and use in Phase I clinical trials","volume":"29","author":"Jones","year":"2002","journal-title":"J Pharma Biol Anal"},{"key":"10.1016\/j.lungcan.2007.06.001_bib5","unstructured":"Gefitinib (IRESSA 250) Prescribing Information, AstraZeneca Japan, 2006."},{"key":"10.1016\/j.lungcan.2007.06.001_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.lungcan.2004.09.002","article-title":"Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases","volume":"47","author":"Rossi","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2007.06.001_bib7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lungcan.2007.06.001_bib8","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2007.06.001_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(03)12190-3","article-title":"Severe acute interstitial pneumonia and gefitinib","volume":"361","author":"Inoue","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2007.06.001_bib10","first-page":"A148","article-title":"A cohort and nested case-control study to quantify the risk of interstitial lung disease (ILD) in Japanese patients with NSCLC treated with gefitinib or chemotherapy","volume":"175","author":"Kudoh","year":"2007","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.lungcan.2007.06.001_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjc.6603393","article-title":"A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations","volume":"95","author":"Asahina","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2007.06.001_bib12","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.2005.05.4692","article-title":"Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations","volume":"24","author":"Inoue","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T16:56:22Z","timestamp":1546707382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500207003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0169500207003261"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2007.06.001","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}